Glucose enhances protein tyrosine phosphatase 1B gene transcription in hepatocytes

Molecular and Cellular Endocrinology

Volumn 271, Issue 1-2, 2007, Pages 64-70

  Inada, Shojiro ^a   Ikeda, Yukio ^a   Suehiro, Tadashi ^a   Takata, Hiroshi ^a   Osaki, Fumiaki ^a   Arii, Kaoru ^a   Kumon, Yoshitaka ^a   Hashimoto, Kozo ^a  

^a KOCHI UNIVERSITY   (Japan)

Author keywords

Glucose; Protein kinase C; Protein tyrosine phosphatase; PTP1B; Sp1; Transcription

Indexed keywords

GLUCOSE; INSULIN RECEPTOR; MESSENGER RNA; MITHRAMYCIN; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE PHOSPHATASE 1B;

ARTICLE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; SIGNAL TRANSDUCTION;

CELL LINE; GENE EXPRESSION REGULATION; GENES, REPORTER; GLUCOSE; HEPATOCYTES; HUMANS; INSULIN; PLICAMYCIN; PROMOTER REGIONS (GENETICS); PROTEIN KINASE C; PROTEIN SYNTHESIS INHIBITORS; PROTEIN-TYROSINE-PHOSPHATASE; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 34249071951     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2007.04.005     Document Type: Article

References (39)

1. Bourdeau A., Dube N., and Tremblay M.L. Cytoplasmic protein tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-PTP. Curr. Opin. Cell Biol. 17 (2005) 203-209
2. Buse M.G. Hexosamines, insulin resistance, and the complications of diabetes: current status. Am. J. Physiol. Endocrinol. Metab. 290 (2006) E1-E8
3. Chae Y.M., Park K.K., Magae J., Lee I.S., Kim C.H., Kim H.C., Hong S., Lee J.G., Choi I.J., Kim H.S., Min K.S., Lee I.K., and Chang Y.C. Sp1-decoy oligodeoxynucleotide inhibits high glucose-induced mesangial cell proliferation. Biochem. Biophys. Res. Commun. 319 (2004) 550-555
4. Chen Y.Q., Su M., Walia R.R., Hao Q., Covington J.W., and Vaughan D.E. Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells. J. Biol. Chem. 273 (1998) 8225-8231
5. Clampit J.E., Meuth J.L., Smith H.T., Reilly R.M., Jirousek M.R., Trevillyan J.M., and Rondinone C.M. Reduction of protein-tyrosine phosphatase-1B increases insulin signaling in FAO hepatoma cells. Biochem. Biophys. Res. Commun. 300 (2003) 261-267
6. Costantino L., and Barlocco D. Inhibitors for proteins endowed with catalytic and non-catalytic activity which recognize pTyr. Curr. Med. Chem. 11 (2004) 2725-2747
7. Dadke S., Cotteret S., Yip S.C., Jaffer Z.M., Haj F., Ivanov A., Rauscher III F., Shuai K., Ng T., Neel B.G., and Chernoff J. Regulation of protein tyrosine phosphatase 1B by sumoylation. Nat. Cell Biol. 9 (2007) 80-85
8. DeFronzo R.A., Bonadonna R.C., and Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15 (1992) 318-368
9. Dubé N., and Tremblay M.L. Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: from diabetes, obesity to cell cycle, and cancer. Biochim. Biophys. Acta 1754 (2005) 108-117
10. Elchebly M., Payette P., Michaliszyn E., Cromlish W., Collins S., Loy A.L., Normandin D., Cheng A., Himms-Hagen J., Chan C.C., Ramachandran C., Gresser M.J., Tremblay M.L., and Kennedy B.P. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283 (1999) 1544-1548
11. Evans J.L., Maddux B.A., and Goldfine I.D. The molecular basis for oxidative stress-induced insulin resistance. Antioxid. Redox. Signal. 7 (2005) 1040-1052
12. Fukada T., and Tonks N.K. The reciprocal role of Egr-1 and Sp family proteins in regulation of the PTP1B promoter in response to the p210 Bcr-Abl oncoprotein-tyrosine kinase. J. Biol. Chem. 276 (2001) 25512-25519
13. Goldstein B.J., Ahmad F., Ding W., Li P.M., and Zhang W.R. Regulation of the insulin signalling pathway by cellular protein-tyrosine phosphatases. Mol. Cell. Biochem. 182 (1998) 91-99
14. Haj F.G., Zabolotny J.M., Kim Y.B., Kahn B.B., and Neel B.G. Liver-specific protein-tyrosine phosphatase 1B (PTP1B) re-expression alters glucose homeostasis of PTP1B-/- mice. J. Biol. Chem. 280 (2005) 15038-15046
15. Hashimoto N., and Goldstein B.J. Differential regulation of mRNAs encoding three protein-tyrosine phosphatases by insulin and activation of protein kinase C. Biochem. Biophys. Res. Commun. 188 (1992) 1305-1311
16. Ide R., Maegawa H., Kikkawa R., Shigeta Y., and Kashiwagi A. High glucose condition activates protein tyrosine phosphatases and deactivates insulin receptor function in insulin-sensitive rat 1 fibroblasts. Biochem. Biophys. Res. Commun. 201 (1994) 71-77
17. Kahn C.R. Banting lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43 (1994) 1066-1084
18. Kaneto H., Nakatani Y., Kawamori D., Miyatsuka T., Matsuoka T.A., Matsuhisa M., and Yamasaki Y. Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic beta-cell dysfunction and insulin resistance. Int. J. Biochem. Cell. Biol. 37 (2005) 1595-1608
19. Kenner K.A., Hill D.E., Olefsky J.M., and Kusari J. Regulation of protein tyrosine phosphatases by insulin and insulin-like growth factor I. J. Biol. Chem. 268 (1993) 25455-25462
20. Klaman L.D., Boss O., Peroni O.D., Kim J.K., Martino J.L., Zabolotny J.M., Moghal N., Lubkin M., Kim Y.B., Sharpe A.H., Stricker-Krongrad A., Shulman G.I., Neel B.G., and Kahn B.B. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell. Biol. 20 (2000) 5479-5489
21. Laybutt D.R., Schmitz-Peiffer C., Saha A.K., Ruderman N.B., Biden T.J., and Kraegen E.W. Muscle lipid accumulation and protein kinase C activation in the insulin-resistant chronically glucose-infused rat. Am. J. Physiol. 277 (1999) E1070-E1076
22. Lee S., Park U., and Lee Y.I. Hepatitis C virus core protein transactivates insulin-like growth factor II gene transcription through acting concurrently on Egr1 and Sp1 sites. Virology 283 (2001) 167-177
23. Maegawa H., Ide R., Hasegawa M., Ugi S., Egawa K., Iwanishi M., Kikkawa R., Shigeta Y., and Kashiwagi A. Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of protein-tyrosine phosphatase activities. J. Biol. Chem. 270 (1995) 7724-7730
24. Marshall S., Garvey W.T., and Traxinger R.R. New insights into the metabolic regulation of insulin action and insulin resistance: role of glucose and amino acids. FASEB J. 5 (1991) 3031-3036
25. McClain D.A., and Crook E.D. Hexosamines and insulin resistance. Diabetes 45 (1996) 1003-1009
26. Nakajima K., Yamauchi K., Shigematsu S., Ikeo S., Komatsu M., Aizawa T., and Hashizume K. Selective attenuation of metabolic branch of insulin receptor down-signaling by high glucose in a hepatoma cell line, HepG2 cells. J. Biol. Chem. 275 (2000) 20880-20886
27. Osaki F., Ikeda Y., Suehiro T., Ota K., Tsuzura S., Arii K., Kumon Y., and Hashimoto K. Roles of Sp1 and protein kinase C in regulation of human serum paraoxonase 1 (PON1) gene transcription in HepG2 cells. Atherosclerosis 176 (2004) 279-287
28. Pal S., Claffey K.P., Cohen H.T., and Mukhopadhyay D. Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta. J. Biol. Chem. 273 (1998) 26277-26280
29. Pirola L., Johnston A.M., and Van Obberghen E. Modulation of insulin action. Diabetologia 47 (2004) 170-184
30. Rafty L.A., and Khachigian L.M. Sp1 phosphorylation regulates inducible expression of platelet-derived growth factor B-chain gene via atypical protein kinase C-zeta. Nucleic Acids Res. 29 (2001) 1027-1033
31. Sayeski P.P., and Kudlow J.E. Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-α gene transcription. J. Biol. Chem. 271 (1996) 15237-15243
32. Shimizu S., Ugi S., Maegawa H., Egawa K., Nishio Y., Yoshizaki T., Shi K., Nagai Y., Morino K., Nemoto K., Nakamura T., Bryer-Ash M., and Kashiwagi A. Protein-tyrosine phosphatase 1B as new activator for hepatic lipogenesis via sterol regulatory element-binding protein-1 gene expression. J. Biol. Chem. 278 (2003) 43095-43101
33. Taghibiglou C., Rashid-Kolvear F., Van Iderstine S.C., Le-Tien H., Fantus I.G., Lewis G.F., and Adeli K. Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance. J. Biol. Chem. 277 (2002) 793-803
34. Takahara T., Kanazu S.I., Yanagisawa S., and Akanuma H. Heterogeneous Sp1 mRNAs in human HepG2 cells include a product of homotypic trans-splicing. J. Biol. Chem. 275 (2000) 38067-38072
35. Ukkola O., and Santaniemi M. Protein tyrosine phosphatase 1B: a new target for the treatment of obesity and associated co-morbidities. J. Intern. Med. 251 (2002) 467-475
36. White M.F. The insulin signalling system and the IRS proteins. Diabetologia 40 Suppl. 2 (1997) S2-S17
37. Wu Y., Ouyang J.P., Wu K., Wang S.S., Wen C.Y., and Xia Z.Y. Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats. Br. J. Pharmacol. 146 (2005) 234-243
38. Zabolotny J.M., Haj F.G., Kim Y.B., Kim H.J., Shulman G.I., Kim J.K., Neel B.G., and Kahn B.B. Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action. J. Biol. Chem. 279 (2004) 24844-24851
39. Zhang Z.Y., and Lee S.Y. PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity. Expert Opin. Invest. Drugs 12 (2003) 223-233